Liver pathology in compound heterozygous patients for hemochromatosis mutations

Liver

Volumn 22, Issue 4, 2002, Pages 295-301

  Schöniger Hekele, Maximilian ^c   Müller, Christian ^a,b   Polli, Claudia ^c   Wrba, Friedrich ^c   Penner, Edward ^c   Ferenci, Peter ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Division of Gastroenterology and Hepatology   (Austria)

^c NONE

Author keywords

C282Y H63D; Compound heterozygous; Hemochromatosis

Indexed keywords

EOSIN; FERRIC FERROCYANIDE; FERRITIN; HEMATOXYLIN; HFE PROTEIN; IRON; TRANSFERRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CADAVER DONOR; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE AMPLIFICATION; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS; HETEROZYGOTE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER STRUCTURE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; TISSUE SECTION; TRANSFERRIN BLOOD LEVEL; WILD TYPE;

ADOLESCENT; ADULT; AGED; DNA MUTATIONAL ANALYSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FERRITINS; HEMOCHROMATOSIS; HETEROZYGOTE; HUMANS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; TRANSFERRIN;

EID: 0036696875     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2002.01597.x     Document Type: Article

References (20)

1. MOIRAND R, JOUANOLLE A M, BRISSOT P, GALL J Y, DAVID V, DEUGNIER Y. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology 1999; 116: 372-77.
2. PIETRANGELO A, MONTOSI G, TOTARO A, et al. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med 1999; 341: 725-32.
3. MURA C, RAGUENES O, FÉREC C. HFE mutations analysis in 711 hemochromatosis probands. Evidence for S65C implication in mild form of hemochromatosis. Blood 1999; 93: 2502-05.
4. OLYNYK J K, CULLEN D J, AQUILIA S, ROSSI E, SUMMERVILLE L, POWELL L W. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341: 718-24.
5. KAZEMI-SHIRAZI L, DATZ C, MAIER-DOBERSBERGER T, et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999; 116: 127-34.
6. ROWE J W, WANDS J R, MEZEY E, et al. Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred. Medicine (Baltimore) 1977; 56: 197-11.
7. DIBISCEGLIE A M, AXIOTIS C A, HOOFNAGLE J H, BACON B R. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102: 2108-13.
8. SEARLE J W, KERR J F R, HALLIDAY J W, et al. Iron storage disease. In: Pathology of the Liver, 2nd edn. MCSWEEN RNM, ANTHONY P P, SCHEUER P J, eds. New York: Churchill Livingstone, 1989: 181-201.
9. KASERER K, FIEDLER R, STEINDL P, MÜLLER C H, WRBA F, FERENCI P. Liver biopsy is a useful predictor of response to interferon-therapy in chronic hepatitis C. Histopathology, 1998; 32: 454-61.
10. DEUGNIER Y M, TURLIN B, POWELL L W, et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron-index. A study of 192 cases. Hepatology 1993; 17: 30-34.
11. LUDWIG J. Histopathological diagnosis and terminology of chronic hepatitis. J Hepatol 1995; 1: 49-53.
12. WEINTRAUB L R, GORAL A, GRASSO J, FRANZBLAU C, SULLIVAN A, SULLIVAN S. Pathogenesis of hepatic fibrosis in experimental iron overload. Br J Haematol 1985; 59: 321-31.
13. BACON B R, OLYNYK J K, BRUNT E M, et al. HFE genotype in patients with hemochromatosis and in patients with liver disease. Ann Intern Med 1999; 130: 953-62.
14. OLYNYK J K. Hereditary hemochromatosis: diagnosis and management in the gene era. Liver 1999; 19: 73-80.
15. LOREAL O, DEUGNIER Y, MOIRAND R, et al. Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients. J Hepatol 1992; 122-27.
16. SMITH B C, GROVE J, GUZAIL M A, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998; 27: 1695-59.
17. STUART K A, BUSFIELD F, JAZWINSKA E C, et al. The C282Y mutation the hemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australien patients. J Hepatol 1998; 28: 404-9.
18. ROSSI E, OLYNYK J K, CULLEN D J, PAPADOPOULOS G, BULSARA M, SUMMERVILLE L, POWELL L W. Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women. Clin Chem 2000; 46: 162-66.
19. DATZ C, HAAS T, RINNER H, SANDHOFER F, PATSCH W, PAULWEBER B. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum-iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency? Clin Chem 1998; 44: 2429-32.
20. GUYADER D, JAQUELINET C, MOIRAND R, et al. Noninvasive prediction of fibrosis in C282Y homozygous haemochromatosis. Gastroenterology 1998; 115: 929-36.